A Randomized, Double-Blind, Placebo-Controlled Study To Investigate The Efficacy And Safety Of Carisbamate (Ykp509) As Adjunctive Treatment For Seizures Associated With Lennox-Gastaut Syndrome In Children And Adults, With Optional Open-Label Extensio
Clinical Trial Grant
Administered By
Pediatrics, Neurology
Awarded By
SK Life Science, Inc
Start Date
May 1, 2023
End Date
November 28, 2025
Administered By
Pediatrics, Neurology
Awarded By
SK Life Science, Inc
Start Date
May 1, 2023
End Date
November 28, 2025